English

INHIBRX, INC.

EDGAR

INBX Quarterly report (10-Q) · filed 2024-05-09

17 filing records in this dataset, filed from 2019-06-03 to 2024-05-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-63.1 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -63050000 USD Source

Free cash flow

-64.2 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -63050000 USD Source
Capital Expenditure: 1119000 USD Source

Cash and cash equivalents: 253 million USD 2024-03-31 Source
Exact value

252500000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 49.2 million shares 2024-03-31 Source
Exact value

49234225 shares

Reported share-count change

12.94% · 5.64 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

43594892 shares · 2023-03-31· Source
49234225 shares · 2024-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.78 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Revenue: 30000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 119000 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 1800000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 166000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 0 USD · 2024-01-01 – 2024-03-31 Source

Net income

-271 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Net income: -47052000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -51789000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -241361000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -147757000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -78710000 USD · 2024-01-01 – 2024-03-31 Source

Operating cash flow

-216 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: -82243000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -39944000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -136488000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -82243000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -193309000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -136488000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -63050000 USD · 2024-01-01 – 2024-03-31 Source

Capital expenditure

5.69 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Capital expenditure: 340000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 23000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 1151000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 340000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 4593000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 1151000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 1119000 USD · 2024-01-01 – 2024-03-31 Source

Free cash flow

-222 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: -82243000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -39944000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -136488000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -82243000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -193309000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -136488000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -63050000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 340000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 23000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 1151000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 340000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 4593000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 1151000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 1119000 USD · 2024-01-01 – 2024-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-05-09.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2023-12-31
Operating income: 5 of 11 periods available· newest 2023-12-31
Net income: 5 of 11 periods available· newest 2023-12-31
Operating cash flow: 5 of 11 periods available· newest 2023-12-31
Capital expenditure: 5 of 11 periods available· newest 2023-12-31
Total assets: 5 of 11 periods available· newest 2023-12-31
Total liabilities: 5 of 11 periods available· newest 2023-12-31
Current assets: 5 of 11 periods available· newest 2023-12-31
Current liabilities: 5 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-17.9%

Prior period

USD 2.19 million

2022-01-01 – 2022-12-31
Current period

USD 1.8 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

1800000 − 2192000 = -392000 USD

2192000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
1800000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Year-over-year change in Revenue: -392000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1800000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1729464 Filing: 000173961424000006 Input fundies:Revenue: 2192000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1730419 Filing: 000173961424000006
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 96.14 million

Prior period

−USD 145.23 million

2022-01-01 – 2022-12-31
Current period

−USD 241.36 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-241361000 − -145226000 = -96135000 USD

-145226000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-241361000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Year-over-year change in Net income: -96135000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -241361000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1414248 Filing: 000173961424000006 Input fundies:NetIncome: -145226000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1415032 Filing: 000173961424000006
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 78.01 million

Prior period

−USD 115.3 million

2022-01-01 – 2022-12-31
Current period

−USD 193.31 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-193309000 − -115301000 = -78008000 USD

-115301000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-193309000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Year-over-year change in Operating cash flow: -78008000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -193309000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1439829 Filing: 000173961424000006 Input fundies:OperatingCashFlow: -115301000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1440493 Filing: 000173961424000006
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+569.5%

Prior period

USD 686,000

2022-01-01 – 2022-12-31
Current period

USD 4.59 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

4593000 − 686000 = 3907000 USD

686000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
4593000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Year-over-year change in Capital expenditure: 3907000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4593000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1441866 Filing: 000173961424000006 Input fundies:CapitalExpenditure: 686000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1442461 Filing: 000173961424000006
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 1.8 million 100% of revenue
Operating costs Derived USD 221.02 million 12,279% of revenue
Operating income −USD 219.22 million −12,179% of revenue
Tax, interest and other Derived USD 22.14 million 1,230% of revenue
Net income −USD 241.36 million −13,409% of revenue

Cash

Operating cash flow −USD 193.31 million −10,739% of revenue
Capital expenditure USD 4.59 million 255% of revenue
Free cash flow Derived −USD 197.9 million −10,995% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 431% of revenue.
2020 Operating loss: operating costs were 623% of revenue.
2021 Operating loss: operating costs were 1,159% of revenue.
2022 Operating loss: operating costs were 5,990% of revenue.
2023 Operating loss: operating costs were 12,279% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	13211000	56925000 Derived	-43714000	7686000 Derived	-51400000	-33889000 Derived	Source 2019-01-01 – 2019-12-31: 13211000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -43714000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -51400000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -32079000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1810000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	12888000	80331000 Derived	-67443000	8681000 Derived	-76124000	-49332000 Derived	Source 2020-01-01 – 2020-12-31: 12888000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -67443000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -76124000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -47968000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1364000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	7231000	83795000 Derived	-76564000	5204000 Derived	-81768000	-81187000 Derived	Source 2021-01-01 – 2021-12-31: 7231000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -76564000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -81768000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -80323000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 864000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	2192000	131309000 Derived	-129117000	16109000 Derived	-145226000	-115987000 Derived	Source 2022-01-01 – 2022-12-31: 2192000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -129117000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -145226000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -115301000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 686000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	1800000	221021000 Derived	-219221000	22140000 Derived	-241361000	-197902000 Derived	Source 2023-01-01 – 2023-12-31: 1800000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -219221000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -241361000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -193309000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 4593000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.8M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	13211000	Revenue: 13211000 Open source
20202020-12-31	Revenue	12888000	Revenue: 12888000 Open source
20212021-12-31	Revenue	7231000	Revenue: 7231000 Open source
20222022-12-31	Revenue	2192000	Revenue: 2192000 Open source
20232023-12-31	Revenue	1800000	Revenue: 1800000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-17.9% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 13211000 Open source
20202020-12-31	Year over year	-2.4%	Revenue: 12888000 Open source Revenue: 13211000 Open source
20212021-12-31	Year over year	-43.9%	Revenue: 7231000 Open source Revenue: 12888000 Open source
20222022-12-31	Year over year	-69.7%	Revenue: 2192000 Open source Revenue: 7231000 Open source
20232023-12-31	Year over year	-17.9%	Revenue: 1800000 Open source Revenue: 2192000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -12,178.9% 2023

Net margin -13,408.9% 2023

Free cash flow margin -10,994.6% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-330.9%	Operating Income: -43714000 Open source Revenue: 13211000 Open source
20202020-12-31	Operating margin	-523.3%	Operating Income: -67443000 Open source Revenue: 12888000 Open source
20212021-12-31	Operating margin	-1,058.8%	Operating Income: -76564000 Open source Revenue: 7231000 Open source
20222022-12-31	Operating margin	-5,890.4%	Operating Income: -129117000 Open source Revenue: 2192000 Open source
20232023-12-31	Operating margin	-12,178.9%	Operating Income: -219221000 Open source Revenue: 1800000 Open source
20192019-12-31	Net margin	-389.1%	Net Income: -51400000 Open source Revenue: 13211000 Open source
20202020-12-31	Net margin	-590.7%	Net Income: -76124000 Open source Revenue: 12888000 Open source
20212021-12-31	Net margin	-1,130.8%	Net Income: -81768000 Open source Revenue: 7231000 Open source
20222022-12-31	Net margin	-6,625.3%	Net Income: -145226000 Open source Revenue: 2192000 Open source
20232023-12-31	Net margin	-13,408.9%	Net Income: -241361000 Open source Revenue: 1800000 Open source
20192019-12-31	Free cash flow margin	-256.5%	Revenue: 13211000 Open source Operating Cash Flow: -32079000 Open source Capital Expenditure: 1810000 Open source
20202020-12-31	Free cash flow margin	-382.8%	Revenue: 12888000 Open source Operating Cash Flow: -47968000 Open source Capital Expenditure: 1364000 Open source
20212021-12-31	Free cash flow margin	-1,122.8%	Revenue: 7231000 Open source Operating Cash Flow: -80323000 Open source Capital Expenditure: 864000 Open source
20222022-12-31	Free cash flow margin	-5,291.4%	Revenue: 2192000 Open source Operating Cash Flow: -115301000 Open source Capital Expenditure: 686000 Open source
20232023-12-31	Free cash flow margin	-10,994.6%	Revenue: 1800000 Open source Operating Cash Flow: -193309000 Open source Capital Expenditure: 4593000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -193.3M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-32079000	Operating Cash Flow: -32079000 Open source
20202020-12-31	Operating cash flow	-47968000	Operating Cash Flow: -47968000 Open source
20212021-12-31	Operating cash flow	-80323000	Operating Cash Flow: -80323000 Open source
20222022-12-31	Operating cash flow	-115301000	Operating Cash Flow: -115301000 Open source
20232023-12-31	Operating cash flow	-193309000	Operating Cash Flow: -193309000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -197.9M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-33889000	Operating Cash Flow: -32079000 Open source Capital Expenditure: 1810000 Open source
20202020-12-31	Free cash flow	-49332000	Operating Cash Flow: -47968000 Open source Capital Expenditure: 1364000 Open source
20212021-12-31	Free cash flow	-81187000	Operating Cash Flow: -80323000 Open source Capital Expenditure: 864000 Open source
20222022-12-31	Free cash flow	-115987000	Operating Cash Flow: -115301000 Open source Capital Expenditure: 686000 Open source
20232023-12-31	Free cash flow	-197902000	Operating Cash Flow: -193309000 Open source Capital Expenditure: 4593000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

85.9% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	228.6%	Total Liabilities: 60551000 Open source Total Assets: 26489000 Open source
20202020-12-31	Liabilities / assets	47.5%	Total Liabilities: 68267000 Open source Total Assets: 143740000 Open source
20212021-12-31	Liabilities / assets	65.2%	Total Liabilities: 98067000 Open source Total Assets: 150450000 Open source
20222022-12-31	Liabilities / assets	80%	Total Liabilities: 232818000 Open source Total Assets: 290875000 Open source
20232023-12-31	Liabilities / assets	85.9%	Total Liabilities: 264390000 Open source Total Assets: 307893000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.25× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	0.76×	Current Assets: 15561000 Open source Current Liabilities: 20570000 Open source
20202020-12-31	Current assets / current liabilities	4.21×	Current Assets: 132172000 Open source Current Liabilities: 31399000 Open source
20212021-12-31	Current assets / current liabilities	6.2×	Current Assets: 139112000 Open source Current Liabilities: 22454000 Open source
20222022-12-31	Current assets / current liabilities	10.17×	Current Assets: 280493000 Open source Current Liabilities: 27576000 Open source
20232023-12-31	Current assets / current liabilities	5.25×	Current Assets: 295358000 Open source Current Liabilities: 56312000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 51.4 million Exact value Exact value: -51400000 USD 2019-01-01 – 2019-12-31: -51400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INHIBRX, INC. · 2019-12-31 INHIBRX, INC. (edgar:1739614) Net Income: -51400000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51400000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961421000047/inbx-20201231.htm#1600453 Filing: 000173961421000047 The citation records this snapshot. The page link may show a newer release later.	−USD 32.08 million Exact value Exact value: -32079000 USD 2019-01-01 – 2019-12-31: -32079000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INHIBRX, INC. · 2019-12-31 INHIBRX, INC. (edgar:1739614) Operating Cash Flow: -32079000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32079000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961421000047/inbx-20201231.htm#1644917 Filing: 000173961421000047 The citation records this snapshot. The page link may show a newer release later.	USD 1.81 million Exact value Exact value: 1810000 USD 2019-01-01 – 2019-12-31: 1810000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INHIBRX, INC. · 2019-12-31 INHIBRX, INC. (edgar:1739614) Capital Expenditure: 1810000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1810000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961421000047/inbx-20201231.htm#1647671 Filing: 000173961421000047 The citation records this snapshot. The page link may show a newer release later.	−USD 33.89 million Calculation and evidence -32079000 − 1810000 USD Exact free cash flow: -33889000 USD 2019-01-01 – 2019-12-31: -32079000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1810000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INHIBRX, INC. · 2019-12-31 INHIBRX, INC. (edgar:1739614) Free cash flow: -33889000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32079000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961421000047/inbx-20201231.htm#1644917 Filing: 000173961421000047 Input fundies:CapitalExpenditure: 1810000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961421000047/inbx-20201231.htm#1647671 Filing: 000173961421000047 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 76.12 million Exact value Exact value: -76124000 USD 2020-01-01 – 2020-12-31: -76124000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INHIBRX, INC. · 2020-12-31 INHIBRX, INC. (edgar:1739614) Net Income: -76124000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -76124000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961422000023/inbx-20211231.htm#1489996 Filing: 000173961422000023 The citation records this snapshot. The page link may show a newer release later.	−USD 47.97 million Exact value Exact value: -47968000 USD 2020-01-01 – 2020-12-31: -47968000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INHIBRX, INC. · 2020-12-31 INHIBRX, INC. (edgar:1739614) Operating Cash Flow: -47968000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47968000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961422000023/inbx-20211231.htm#1532609 Filing: 000173961422000023 The citation records this snapshot. The page link may show a newer release later.	USD 1.36 million Exact value Exact value: 1364000 USD 2020-01-01 – 2020-12-31: 1364000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INHIBRX, INC. · 2020-12-31 INHIBRX, INC. (edgar:1739614) Capital Expenditure: 1364000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1364000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961422000023/inbx-20211231.htm#1535339 Filing: 000173961422000023 The citation records this snapshot. The page link may show a newer release later.	−USD 49.33 million Calculation and evidence -47968000 − 1364000 USD Exact free cash flow: -49332000 USD 2020-01-01 – 2020-12-31: -47968000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1364000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INHIBRX, INC. · 2020-12-31 INHIBRX, INC. (edgar:1739614) Free cash flow: -49332000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47968000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961422000023/inbx-20211231.htm#1532609 Filing: 000173961422000023 Input fundies:CapitalExpenditure: 1364000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961422000023/inbx-20211231.htm#1535339 Filing: 000173961422000023 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 81.77 million Exact value Exact value: -81768000 USD 2021-01-01 – 2021-12-31: -81768000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INHIBRX, INC. · 2021-12-31 INHIBRX, INC. (edgar:1739614) Net Income: -81768000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -81768000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961423000020/inbx-20221231.htm#1475688 Filing: 000173961423000020 The citation records this snapshot. The page link may show a newer release later.	−USD 80.32 million Exact value Exact value: -80323000 USD 2021-01-01 – 2021-12-31: -80323000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INHIBRX, INC. · 2021-12-31 INHIBRX, INC. (edgar:1739614) Operating Cash Flow: -80323000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -80323000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961423000020/inbx-20221231.htm#1512328 Filing: 000173961423000020 The citation records this snapshot. The page link may show a newer release later.	USD 864,000 Exact value Exact value: 864000 USD 2021-01-01 – 2021-12-31: 864000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INHIBRX, INC. · 2021-12-31 INHIBRX, INC. (edgar:1739614) Capital Expenditure: 864000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 864000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961423000020/inbx-20221231.htm#1515056 Filing: 000173961423000020 The citation records this snapshot. The page link may show a newer release later.	−USD 81.19 million Calculation and evidence -80323000 − 864000 USD Exact free cash flow: -81187000 USD 2021-01-01 – 2021-12-31: -80323000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 864000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INHIBRX, INC. · 2021-12-31 INHIBRX, INC. (edgar:1739614) Free cash flow: -81187000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -80323000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961423000020/inbx-20221231.htm#1512328 Filing: 000173961423000020 Input fundies:CapitalExpenditure: 864000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961423000020/inbx-20221231.htm#1515056 Filing: 000173961423000020 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 145.23 million Exact value Exact value: -145226000 USD 2022-01-01 – 2022-12-31: -145226000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INHIBRX, INC. · 2022-12-31 INHIBRX, INC. (edgar:1739614) Net Income: -145226000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -145226000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1415032 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.	−USD 115.3 million Exact value Exact value: -115301000 USD 2022-01-01 – 2022-12-31: -115301000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INHIBRX, INC. · 2022-12-31 INHIBRX, INC. (edgar:1739614) Operating Cash Flow: -115301000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -115301000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1440493 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.	USD 686,000 Exact value Exact value: 686000 USD 2022-01-01 – 2022-12-31: 686000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INHIBRX, INC. · 2022-12-31 INHIBRX, INC. (edgar:1739614) Capital Expenditure: 686000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 686000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1442461 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.	−USD 115.99 million Calculation and evidence -115301000 − 686000 USD Exact free cash flow: -115987000 USD 2022-01-01 – 2022-12-31: -115301000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 686000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INHIBRX, INC. · 2022-12-31 INHIBRX, INC. (edgar:1739614) Free cash flow: -115987000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -115301000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1440493 Filing: 000173961424000006 Input fundies:CapitalExpenditure: 686000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1442461 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 241.36 million Exact value Exact value: -241361000 USD 2023-01-01 – 2023-12-31: -241361000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Net Income: -241361000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -241361000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1414248 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.	−USD 193.31 million Exact value Exact value: -193309000 USD 2023-01-01 – 2023-12-31: -193309000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Operating Cash Flow: -193309000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -193309000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1439829 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.	USD 4.59 million Exact value Exact value: 4593000 USD 2023-01-01 – 2023-12-31: 4593000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Capital Expenditure: 4593000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4593000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1441866 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.	−USD 197.9 million Calculation and evidence -193309000 − 4593000 USD Exact free cash flow: -197902000 USD 2023-01-01 – 2023-12-31: -193309000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 4593000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INHIBRX, INC. · 2023-12-31 INHIBRX, INC. (edgar:1739614) Free cash flow: -197902000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:11:57Z Snapshot: 1cb6f4bbe2ab555d4cad83fa401e44f589c83483be0f2f269aa5ceec42a54e21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1739614?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -193309000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1439829 Filing: 000173961424000006 Input fundies:CapitalExpenditure: 4593000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000006/inbx-20231231.htm#1441866 Filing: 000173961424000006 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

17 filings · 1,257 latest values · 1,257 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001739614, 1739614, INBX, edgar:1739614

Also known as INHIBRX, INC., Inhibrx, Inc.

INHIBRX, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation